Company intelligence / Profile preview

BrainPatch

Ownership: Private
Development stage: Commercial

Overview

BrainPatch has developed a patented non-invasive neurostimulation headset ("neuro-headphone") that delivers on-demand brain stimulation to promote relaxation, stress relief, improved focus, and meditation-like effects. The company has achieved product certification in key markets and is preparing for commercial scale-up following successful safety/efficacy testing. Early user feedback highlights rapid onset of effects with no after-effects. Clinical results are not detailed but the company emphasizes rigorous safety/efficacy validation.

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapy (non-invasive neurostimulation)
Industry: Therapeutic Medical Devices

Partnerships

UK manufacturing partner for scaling productionNo major pharma or biotech partnerships disclosed as of June 2025.

Beyond the preview

Go deeper on BrainPatch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrainPatch.

Explore the full profile